IPH-2101 (NN-1975), a fully human monoclonal antibody developed for patients with acute myeloid leukemia.
Investigated for use/treatment in leukemia (myeloid) and multiple myeloma.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.